Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease
Wenwen Wang, Aihua Mei, Hang Qian, et al.
International Journal of COPD (2023) Vol. Volume 18, pp. 129-137
Open Access | Times Cited: 19

Showing 19 citing articles:

Mapping the effectiveness and risks of GLP-1 receptor agonists
Yan Xie, Taeyoung Choi, Ziyad Al‐Aly
Nature Medicine (2025)
Closed Access | Times Cited: 19
The role of glucagon-like peptide-1 receptor (GLP-1R) agonists in enhancing endothelial function: a potential avenue for improving heart failure with preserved ejection fraction (HFpEF)
Darshan Hullon, Ghasaq K. Subeh, Yu.V. Volkova, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer
Shahad Sabaawi Ibrahim, Raghad Sabaawi Ibrahim, Batoul Arabi, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 4, pp. 1297-1314
Open Access | Times Cited: 11
Association of GLP-1 Receptor Agonists with Chronic Obstructive Pulmonary Disease Exacerbations among Patients with Type 2 Diabetes
Dinah Foer, Zachary H. Strasser, Jing Cui, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 208, Iss. 10, pp. 1088-1100
Closed Access | Times Cited: 22
Two for the price of one: GLP-1 analogues, a new approach in treating severe COPD patients with diabetes
Augusta Beech, Ernesto Crisafulli
ERJ Open Research (2025) Vol. 11, Iss. 2, pp. 01133-2024
Open Access
Glucagon-Like Peptide 1 Receptor (Glp1r) Deficiency Does Not Appreciably Alter Airway Inflammation or Gut-Lung Microbiome Axis in a Mouse Model of Obese Allergic Airways Disease and Bariatric Surgery
Yeon Ji Kim, Victoria M Ihrie, Pixu Shi, et al.
Journal of Asthma and Allergy (2025) Vol. Volume 18, pp. 285-305
Open Access
Lipid metabolism reprogramming in chronic obstructive pulmonary disease
Qianqian Liang, Yide Wang, Zheng Li
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
The Real-World Impact of Glucagon-Like Peptide 1 Receptor Agonists on Asthma Control in People with High-Risk Asthma and Obesity
Alan Kaplan, Heath Heatley, Jonathan N. Townend, et al.
Advances in Therapy (2025)
Open Access
Leptin and Insulin in COPD: Unveiling the Metabolic-Inflammatory Axis—A Narrative Review
Oana Maria Catana, Alexandra Floriana Nemeş, Ramona Cioboată, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2611-2611
Open Access
An opinion piece: Extracting multisystem insights from a single chest CT scan in patients with COPD
Daniel Genkin, Miranda Kirby
Canadian Journal of Respiratory Critical Care and Sleep Medicine (2025), pp. 1-7
Closed Access
Hyperglycaemia and Chronic Obstructive Pulmonary Disease
Mario Cazzola, Paola Rogliani, Josuel Ora, et al.
Diagnostics (2023) Vol. 13, Iss. 21, pp. 3362-3362
Open Access | Times Cited: 9
Combined Exercise Training and Nutritional Interventions or Pharmacological Treatments to Improve Exercise Capacity and Body Composition in Chronic Obstructive Pulmonary Disease: A Narrative Review
Bente Brauwers, Felipe Machado, Rosanne J.H.C.G. Beijers, et al.
Nutrients (2023) Vol. 15, Iss. 24, pp. 5136-5136
Open Access | Times Cited: 9
Genetic variations in anti-diabetic drug targets and COPD risk: evidence from mendelian randomization
Yue Su, Youqian Zhang, Jin‐Fu Xu
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Multi-modal transcriptomic analysis reveals metabolic dysregulation and immune responses in chronic obstructive pulmonary disease
Xiufang Luo, W. Zeng, Jingyi Tang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease
Tianyu Wang, Juncan Ding, Xinyi Cheng, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic Islets
Joshua L. Reed, Stephen C. Bain, Venkateswarlu Kanamarlapudi
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 2419-2456
Open Access
Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?
Miodrag Janić, Sabina Škrgat, Matevž Harlander, et al.
Medicina (2024) Vol. 60, Iss. 12, pp. 2030-2030
Open Access
Sirtuins and mechanisms of diabetic lung damage: a scientific discussion. A review
S. L. Babak, М. В. Горбунова, A.G. Malyavin, et al.
Consilium Medicum (2024) Vol. 26, Iss. 9, pp. 624-627
Open Access
Role of Antioxidant Therapy in Respiratory Disease Management
Baby Bhattacharya, Naina Devi, Sanshita, et al.
Antioxidants (2024), pp. 219-255
Open Access
Page 1

Scroll to top